Expert Interview
A Second Look at Pfizer's oral COVID-19 antiviral Paxlovid
Ticker(s): PFEInstitution: Briova/Axelacare
- Clinical pharmacy specialist and manager, very dedicated to delivering quality outcomes
for patients
- From performing analytics to pinpointing and assessing opportunities for
quality improvements and cost savings, I've delivered a range of management and leadership functions within
the healthcare space.
- Clinical and therapeutic knowledge of specialty disease states including Rheumatology, Oncology, Hematology,
MS, ID, HepC, Infectious disease, Cardiology, Immunology, Pulmonology, and Endocrinology
- Has prescribed Paxlovid. Currently manages 15 course treatments with patients.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
